X T L Biopharmaceuticals reported $-255K in Net Income for its fiscal quarter ending in December of 2024.





Net Income Change Date
Alaunos Therapeutics USD -952K 54K Jun/2026
Bioline Rx USD -3.03M 1.42M Jun/2026
Teva Pharmaceutical Industries USD 233M 809M Sep/2026
X T L Biopharmaceuticals USD -255K 298K Dec/2024